In a standard colonoscopy, as many as one-third of colorectal polyps and adenomas—typically benign clumps of cells that form on the lining of the colon and may be precursors to cancer—can go by undetected.
Hoping to cut down on these inaccuracies is Medtronic, the global distributor of an artificial intelligence system originally developed by Cosmo Pharmaceuticals that aims to increase the number of precancerous polyps detected during a colonoscopy.